| Combination of gene expression signature and model for end-stage liver disease score predicts survival of patients with severe alcoholic hepatitis E Trépo, N Goossens, N Fujiwara, WM Song, A Colaprico, A Marot, ... Gastroenterology 154 (4), 965-975, 2018 | 54 | 2018 |
| Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance C Liefferinckx, C Minsart, A Cremer, L Amininejad, V Tafciu, ... European journal of gastroenterology & hepatology 31 (4), 478-485, 2019 | 34 | 2019 |
| Analysis of genes associated with monogenic primary immunodeficiency identifies rare variants in XIAP in patients with Crohn’s disease L Amininejad, B Charloteaux, E Theatre, C Liefferinckx, J Dmitrieva, ... Gastroenterology 154 (8), 2165-2177, 2018 | 27 | 2018 |
| Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome E Weiss, PE Rautou, M Fasseu, M Giabicani, M de Chambrun, JH Wan, ... Journal of hepatology 66 (5), 930-941, 2017 | 26 | 2017 |
| New insights in acetaminophen toxicity: HMGB1 contributes by itself to amplify hepatocyte necrosis in vitro through the TLR4-TRIF-RIPK3 axis C Minsart, C Liefferinckx, A Lemmers, C Dressen, E Quertinmont, ... Scientific reports 10 (1), 5557, 2020 | 22 | 2020 |
| Infliximab trough levels at induction to predict treatment failure during maintenance C Liefferinckx, C Minsart, JF Toubeau, A Cremer, L Amininejad, ... Inflammatory bowel diseases 23 (8), 1371-1381, 2017 | 20 | 2017 |
| I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease L Peyrin-Biroulet, JF Rahier, J Kirchgesner, V Abitbol, S Shaji, A Armuzzi, ... Clinical Gastroenterology and Hepatology 21 (3), 771-788. e10, 2023 | 17 | 2023 |
| N-acetylcysteine and glycyrrhizin combination: Benefit outcome in a murine model of acetaminophen-induced liver failure C Minsart, S Rorive, A Lemmers, E Quertinmont, T Gustot World Journal of Hepatology 12 (9), 596, 2020 | 14 | 2020 |
| P346 Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn’s disease patients C Liefferinckx, M Fassin, D Thomas, C Minsart, A Cremer, L Amininejad, ... Journal of Crohn's and Colitis 14 (Supplement_1), S331-S333, 2020 | 5 | 2020 |
| New approach to determine the healthy immune variations by combining clustering methods C Liefferinckx, Z De Grève, JF Toubeau, H Perée, E Quertinmont, V Tafciu, ... Scientific reports 11 (1), 8917, 2021 | 3 | 2021 |
| Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn’s disease C Liefferinckx, A Hubert, D Thomas, J Bottieau, C Minsart, A Cremer, ... Digestive and Liver Disease 55 (3), 366-372, 2023 | 2 | 2023 |
| Mo1430-Hepatocyte Release of HMGB1 During Acetaminophen-Induced Liver Injury and Deleterious Feed-Forward Process: Implication of Necroptosis Through TRIF/RIPK3 Axis C Minsart, C Liefferinckx, A Lemmers, E Quertinmont, C Dressen, ... Gastroenterology 154 (6), S-1204, 2018 | 2 | 2018 |
| Microsatellite polymorphism in the heme oxygenase-1 gene promoter is not associated with alcoholic liver disease severity A Lemaire, E Trépo, R Ouziel, T Gustot, C Moreno, D Degré, C Minsart, ... Hepatology 59 (1), 352-353, 2014 | 2 | 2014 |
| 506–Combination of Glycyrrhizin and N-Acetylcysteine: Benefit Outcome in a Murine Model of Acetaminophen-Induced Liver Failure C Minsart, S Rorive, E Quertinmont, A Lemmers, T Gustot Gastroenterology 156 (6), S-1204, 2019 | 1 | 2019 |
| Lipopolysaccharide-Binding Protein (LBP) in Crohn's Disease (CD) Patients: A Promising Non-Invasive Biomarker Monitoring Disease Activity C Minsart, L Toris, C Husson, D Franchimont, C Liefferinckx JOURNAL OF CROHNS & COLITIS 18, I854-I856, 2024 | | 2024 |
| P418 Lipopolysaccharide-Binding Protein (LBP) in Crohn's Disease (CD) Patients: A Promising Non-Invasive Biomarker Monitoring Disease Activity C Minsart, L Toris, C Husson, D Franchimont, C Liefferinckx Journal of Crohn's and Colitis 18 (Supplement_1), i862-i864, 2024 | | 2024 |
| Étude de l’implication de la protéine High-Mobility Group Box 1 dans les lésions hépatiques induites par le paracétamol: dissection des voies de signalisation et ciblage … C Minsart, T Gustot Rev Med Brux 43, 203-208, 2022 | | 2022 |
| Involvement of High Mobility Group Box 1 protein in acetaminophen-induced liver injury: dissection of signaling pathways and potential therapeutic targeting C Minsart Université libre de Bruxelles, 2021 | | 2021 |
| DOP38 Prevalence of fatigue in a severe inflammatory bowel disease cohort highly exposed to biologics C Liefferinckx, M El Hamdi, M Fassin, A Cremer, C Minsart, L Amininejad, ... Journal of Crohn's and Colitis 14 (Supplement_1), S075-S076, 2020 | | 2020 |
| SUN-PO224: Prevalence of Malnutrition in a Cohort of Crohn’s Disease Patients According to the New GLIM Criteria E Brouyère, L Amininejad, A Cremer, C Liefferinckx, C Minsart, J Devière, ... Clinical Nutrition 38, S142-S143, 2019 | | 2019 |
